GLUT1 Promotes Squamous Metaplasia in Eosinophilic Chronic Rhinosinusitis with Nasal Polyps
American Journal of Rhinology & Allergy · 2025
DOI: 10.1177/19458924251342999 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Rhinology & Allergy, 2025. Verfasst von Shouming Cao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming, People's Republic of China. Hauptthemen laut MEDLINE: Glucose Transporter Type 1, Sinusitis, Rhinitis, Nasal Polyps. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: The Yunnan Provincial Department of Education Science Research Fund Project.
Abstract (Originalsprache)
Background
Squamous metaplasia is commonly observed in eosinophilic chronic rhinosinusitis with nasal polyps (eCRSwNP). However, its underlying mechanisms remain unclear. This study aimed to evaluate the role of glucose transporter 1 (GLUT1) in the development of squamous metaplasia in eCRSwNP.
Methods
Tissue proteomics was employed to identify disease-specific proteins in eCRSwNP. Immunofluorescence, western blotting, and RT-qPCR were used for validation. Human nasal epithelial cells were utilized to assess GLUT1 expression and its regulatory mechanisms. A chronic rhinosinusitis with nasal polyps (CRSwNP) mouse model was used to examine the effect of GLUT1 inhibition on squamous metaplasia and nasal inflammation.
Results
Proteomic analysis revealed a disease-specific protein expression profile in eCRSwNP polyps. Cohort validation demonstrated that GLUT1 and keratin 13 (KRT13) expression levels were significantly higher in the eCRSwNP group, with expression primarily localized in the epithelial regions. GLUT1 expression was positively correlated with the incidence of squamous metaplasia as well as KRT13 and involucrin (IVL) expression. In vitro experiments confirmed that combined Interleukin (IL)-4/IL-13 treatment upregulated GLUT1, KRT13, and IVL expression in human nasal epithelial cells in a dose-dependent manner, whereas GLUT1 inhibition reduced KRT13 and IVL expression, possibly through suppression of the PI3K-AKT signaling pathway. Animal experiments demonstrated that GLUT1 inhibition alleviated squamous metaplasia and inflammation in the nasal mucosa of mice.
Conclusion
Elevated GLUT1 expression plays a key role in driving squamous metaplasia in eCRSwNP. GLUT1 inhibition attenuates nasal epithelial squamous metaplasia and inflammation in CRSwNP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming, People's Republic of China.
- Department of Otolaryngology-Head and Neck Surgery, Yanan Hospital of Kunming Medical University, Kunming, People's Republic of China.
ORCID-Profile: Haiying Wu
Förderung
- The Yunnan Provincial Department of Education Science Research Fund Project
Zitieren
APA
Cao, S., Niu, Y., Lou, W., Wen, N., Chen, R., Huang, H., Su, Y., & Wu, H. (2025). GLUT1 Promotes Squamous Metaplasia in Eosinophilic Chronic Rhinosinusitis with Nasal Polyps. American Journal of Rhinology & Allergy. https://doi.org/10.1177/19458924251342999
Vancouver
Cao S, Niu Y, Lou W, Wen N, Chen R, Huang H, et al. GLUT1 Promotes Squamous Metaplasia in Eosinophilic Chronic Rhinosinusitis with Nasal Polyps. American Journal of Rhinology & Allergy. 2025. doi:10.1177/19458924251342999
BibTeX
@article{Cao2025,
author = {Cao, Shouming and Niu, Yan and Lou, Wenrong and Wen, Nannan and Chen, Rui and Huang, Haosu and Su, Yuchao and Wu, Haiying},
title = {GLUT1 Promotes Squamous Metaplasia in Eosinophilic Chronic Rhinosinusitis with Nasal Polyps},
journal = {American Journal of Rhinology & Allergy},
year = {2025},
doi = {10.1177/19458924251342999}
}
EUVIMED